Literature DB >> 12495800

Establishing the feasibility of performance measures for alcohol and other drugs.

Deborah W Garnick1, Margaret T Lee, Mady Chalk, David Gastfriend, Constance M Horgan, Frank McCorry, A Thomas McLellan, Elizabeth Levy Merrick.   

Abstract

The Washington Circle (a multiple-disciplinary group of providers, researchers, managed care representatives, and public policy representatives) examined three performance measures for alcohol and other drug (AOD) services. These measures, which were developed and applied to managed care organizations' administrative data for their commercial enrollees, are: (a) identification, the percent of adult enrollees with AOD diagnoses; (b) initiation, the percent of adults with an inpatient AOD admission or with an index outpatient visit for AOD abuse or dependence and any additional AOD services within 14 days of identification; and (c) engagement, the percent of adults diagnosed with AOD disorders that receives two additional AOD services within 30 days of the initiation of care. We conclude that using administrative databases to compare managed care organizations' performance is feasible, meaningful and informative. The article discusses issues in interpreting performance measures in several areas: organizational structure of alcohol and other drug services, information available for measurement, and computational issues.

Entities:  

Mesh:

Year:  2002        PMID: 12495800     DOI: 10.1016/s0740-5472(02)00303-3

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  57 in total

1.  Addiction treatment agencies' use of data: a qualitative assessment.

Authors:  Jennifer P Wisdom; James H Ford Ii; Randy A Hayes; Eldon Edmundson; Kim Hoffman; Dennis McCarty
Journal:  J Behav Health Serv Res       Date:  2006-10       Impact factor: 1.505

2.  Program structure, staff perceptions, and client engagement in treatment.

Authors:  Kirk M Broome; Patrick M Flynn; Danica K Knight; D Dwayne Simpson
Journal:  J Subst Abuse Treat       Date:  2007-04-16

3.  Effect of insurance parity on substance abuse treatment.

Authors:  Vanessa Azzone; Richard G Frank; Sharon-Lise T Normand; M Audrey Burnam
Journal:  Psychiatr Serv       Date:  2011-02       Impact factor: 3.084

4.  Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders.

Authors:  Susan M Paddock; Kimberly A Hepner; Teresa Hudson; Songthip Ounpraseuth; Amy M Schrader; Greer Sullivan; Katherine E Watkins
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

5.  Reducing readmissions to detoxification: an interorganizational network perspective.

Authors:  Suzanne E Spear
Journal:  Drug Alcohol Depend       Date:  2014-01-25       Impact factor: 4.492

6.  Rates and Impact of Adherence to Recommended Care for Unhealthy Alcohol Use.

Authors:  Kimberly A Hepner; Susan M Paddock; Katherine E Watkins; Katherine J Hoggatt; Lisa V Rubenstein; Andy Bogart; Praise O Iyiewuare; Susan C Rosenbluth; Harold Alan Pincus
Journal:  J Gen Intern Med       Date:  2018-11-27       Impact factor: 5.128

7.  Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV.

Authors:  Derek D Satre; Gerald N DeLorenze; Charles P Quesenberry; Ailin Tsai; Constance Weisner
Journal:  Psychiatr Serv       Date:  2013-08-01       Impact factor: 3.084

8.  Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.

Authors:  Cindy Parks Thomas; Deborah W Garnick; Constance M Horgan; Kay Miller; Alex H S Harris; Melissa M Rosen
Journal:  J Subst Abuse Treat       Date:  2013-03-13

9.  Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.

Authors:  Katherine E Watkins; Susan M Paddock; Teresa J Hudson; Songthip Ounpraseuth; Amy M Schrader; Kimberly A Hepner; Greer Sullivan
Journal:  J Subst Abuse Treat       Date:  2016-06-07

10.  Effect of quality chronic disease management for alcohol and drug dependence on addiction outcomes.

Authors:  Theresa W Kim; Richard Saitz; Debbie M Cheng; Michael R Winter; Julie Witas; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2012-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.